Impact of SGLT2 Inhibitors on Tumor Development Risk in Type 2 Diabete

Introduction

The global prevalence of type 2 diabetes (T2D) continues to rise, now affecting over 400 million individuals worldwide.¹ Beyond its well-established complications such as cardiovascular disease and kidney failure, T2D has also been…